| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medical Genetics [E. A., S. R., A. L., A. H., L. A. A.] and Pathology [R. S.], Haartman Institute, University of Helsinki, FIN-00014 Helsinki, Finland; and Department of Genetics [R. A. L.], Institute of Cancer Research, and Departments of Pathology [A. E. S.] and Medical Oncology and Radiotherapy [S. D. F.], The Norwegian Radium Hospital, 0310 Oslo, Norway
Germ-line mutations in a serine/threonine kinase gene, LKB1, were recently shown to underlie Peutz-Jeghers syndrome (PJS), a hereditary disorder that predisposes to benign and malignant tumors of multiple organ systems. Most mutations that have been described thus far dramatically change the predicted protein and are likely to be of an inactivating nature. This observation and a previous observation that the LKB1 locus is often deleted in PJS polyps suggest that the gene may function as a tumor suppressor. We examined whether somatic mutations in this gene are present in sporadic carcinomas of the colon and testis, tumors that are characteristic of PJS. First, 20 randomly selected colorectal and 28 testicular tumors were analyzed by single-strand conformation polymorphism analysis. No mutations in LKB1 were found in colorectal tumors. One testicular tumor displayed a heterozygous missense type variant, in which glycine 163 was changed to aspartic acid. This change was absent in the DNA of normal tissue. To better focus our efforts, we tested 75 additional colon carcinomas for loss of heterozygosity at 19p, where LKB1 is localized. Of 75 samples analyzed, 50 were informative with a closely linked marker, D19S886, and 13 (26%) of these displayed loss of heterozygosity. The 13 tumors were scrutinized for LKB1 mutations by genomic sequencing. This analysis revealed no changes. Together, these findings suggest that somatic mutations of LKB1 are not frequent in colorectal and testicular cancer.
1 This work was supported by the Academy of Finland, the Finnish Cancer Society, the Helsinki University Central Hospital, and the European Commission.
2 To whom requests for reprints should be addressed, at Department of Medical Genetics, Haartman Institute, P.O. Box 21 (Haartmaninkatu 3), University of Helsinki, Fin-00014 Helsinki, Finland. Phone: 358-9-19126278; Fax: 358-9-19126677; E-mail: lauri.aaltonen@helsinki.fi.
Received 2/11/98. Accepted 3/31/98.
This article has been cited by other articles:
![]() |
D. Zhong, X. Liu, F. R. Khuri, S.-Y. Sun, P. M. Vertino, and W. Zhou LKB1 Is Necessary for Akt-Mediated Phosphorylation of Proapoptotic Proteins Cancer Res., September 15, 2008; 68(18): 7270 - 7277. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Payne and C. J. Kemp Tumor suppressor genetics Carcinogenesis, December 1, 2005; 26(12): 2031 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A Marignani LKB1, the multitasking tumour suppressor kinase J. Clin. Pathol., January 1, 2005; 58(1): 15 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sanchez-Cespedes, P. Parrella, M. Esteller, S. Nomoto, B. Trink, J. M. Engles, W. H. Westra, J. G. Herman, and D. Sidransky Inactivation of LKB1/STK11 Is a Common Event in Adenocarcinomas of the Lung Cancer Res., July 1, 2002; 62(13): 3659 - 3662. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sato, C. Rosty, M. Jansen, N. Fukushima, T. Ueki, C. J. Yeo, J. L. Cameron, C. A. Iacobuzio-Donahue, R. H. Hruban, and M. Goggins STK11/LKB1 Peutz-Jeghers Gene Inactivation in Intraductal Papillary-Mucinous Neoplasms of the Pancreas Am. J. Pathol., December 1, 2001; 159(6): 2017 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jarrett, J. Blancato, T. Cao, D. S. Bressette, M. Cepeda, P. E. Young, C. R. King, and S. W. Byers Human APC2 Localization and Allelic Imbalance Cancer Res., November 1, 2001; 61(21): 7978 - 7984. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Olschwang, C. Boisson, and G. Thomas Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma J. Med. Genet., June 1, 2001; 38(6): 356 - 360. [Abstract] [Full Text] |
||||
![]() |
M M Entius, J J Keller, A M Westerman, B P van Rees, M-L F van Velthuysen, A F P M de Goeij, J H P Wilson, F M Giardiello, and G J A Offerhaus Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome J. Clin. Pathol., February 1, 2001; 54(2): 126 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyaki, T. Iijima, K. Hosono, R. Ishii, M. Yasuno, T. Mori, M. Toi, T. Hishima, N. Shitara, K. Tamura, et al. Somatic Mutations of LKB1 and {beta}-Catenin Genes in Gastrointestinal Polyps from Patients with Peutz-Jeghers Syndrome Cancer Res., November 1, 2000; 60(22): 6311 - 6313. [Abstract] [Full Text] |
||||
![]() |
L F Forster, S Defres, D R Goudie, D U Baty, and F A Carey An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers J. Clin. Pathol., October 1, 2000; 53(10): 791 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Trojan, A Brieger, J Raedle, M Esteller, and S Zeuzem 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer Gut, August 1, 2000; 47(2): 272 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Launonen, E. Avizienyte, A. Loukola, P. Laiho, R. Salovaara, H. Järvinen, J.-P. Mecklin, A. Oku, M. Shimane, H. C. Kim, et al. No Evidence of Peutz-Jeghers Syndrome Gene LKB1 Involvement in Left-sided Colorectal Carcinomas Cancer Res., February 1, 2000; 60(3): 546 - 548. [Abstract] [Full Text] |
||||
![]() |
D. C. Connolly, H. Katabuchi, W. A. Cliby, and K. R. Cho Somatic Mutations in the STK11/LKB1 Gene Are Uncommon in Rare Gynecological Tumor Types Associated with Peutz-Jegher’s Syndrome Am. J. Pathol., January 1, 2000; 156(1): 339 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. CHEN, E. AVIZIENYTE, S. ROTH, I. LEIVO, A. A MAKITIE, L.-M. AALTONEN, and L. A AALTONEN PTEN and LKB1 genes in laryngeal tumours J. Med. Genet., December 1, 1999; 36(12): 943 - 944. [Full Text] [PDF] |
||||
![]() |
M. Tiainen, A. Ylikorkala, and T. P. Makela Growth suppression by Lkb1 is mediated by a G1 cell cycle arrest PNAS, August 3, 1999; 96(16): 9248 - 9251. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Su, R. H. Hruban, R. K. Bansal, G. S. Bova, D. J. Tang, M. C. Shekher, A. M. Westerman, M. M. Entius, M. Goggins, C. J. Yeo, et al. Germline and Somatic Mutations of the STK11/LKB1 Peutz-Jeghers Gene in Pancreatic and Biliary Cancers Am. J. Pathol., June 1, 1999; 154(6): 1835 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z-J Wang, M Churchman, E Avizienyte, C McKeown, S Davies, D G R Evans, A Ferguson, I Ellis, W.-H. Xu, Z.-Y. Yan, et al. Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients J. Med. Genet., May 1, 1999; 36(5): 365 - 368. [Abstract] [Full Text] |
||||
![]() |
E. Avizienyte, A. Loukola, S. Roth, A. Hemminki, M. Tarkkanen, R. Salovaara, J. Arola, R. Butzow, K. Husgafvel-Pursiainen, A. Kokkola, et al. LKB1 Somatic Mutations in Sporadic Tumors Am. J. Pathol., March 1, 1999; 154(3): 677 - 681. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |